pharma · Eosinophilic esophagitis · Narcolepsy
Bioprojet
Bioprojet Pharma
Bioprojet patent portfolio — 9 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 9 rue Rameau, Paris, 75002, FR
- Employees
- 166
- Programs
- 11
- Drugs
- 19
- Patents
- 9
Bioprojet patents
9 pharmaceutical patents indexed for Bioprojet. 0 expire within 24 months.
Bioprojet has 9 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
EP 4732903
COKRISTALLE VON PITOLISTANTHYDROCHLORID
granted -
EP 4681704
NEUE FORMULIERUNGEN VON PITOLISANT
granted -
US 2025120959
NEW FORMULATIONS OF PITOLISANT AND METHODS OF USE
granted -
US 2024327366
POLYMORPH FORM OF PITOLISANT HYDROCHLORIDE
granted -
EP 3906927
VERWENDUNG VON DOPAMIN-D3-TEILAGONISTEN ZUR BEHANDLUNG VON STÖRUNGEN DES ZENTRALEN NERVENSYSTEMS
granted -
US 2020024256
TETRAHYDRATE OF H3 LIGAND, ITS PROCESS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
granted -
EP 3378477
NEUE THERAPEUTISCHE VERWENDUNGEN VON H3-LIGANDEN
granted -
EP 2511275
Neuartige Piperidinyl-monocarboxylsäuren als S1P1 Rezeptoragonisten
granted -
EP 2014653
Neue Dicarbonsäurederivate als S1P1 Rezeptor Agonisten
granted
Frequently asked questions
How many patents does Bioprojet have?
9 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Bioprojet patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.